Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,271 | 777 | 99.7% |
| Education | $37.37 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,489 | 59 | $0 (2024) |
| Novo Nordisk Inc | $1,375 | 128 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,303 | 75 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,240 | 55 | $0 (2022) |
| PFIZER INC. | $908.41 | 73 | $0 (2024) |
| Lilly USA, LLC | $594.82 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $509.59 | 26 | $0 (2022) |
| Allergan, Inc. | $476.59 | 42 | $0 (2020) |
| Merck Sharp & Dohme LLC | $431.42 | 41 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $430.91 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $935.95 | 39 | AstraZeneca Pharmaceuticals LP ($183.05) |
| 2023 | $842.19 | 41 | GlaxoSmithKline, LLC. ($314.43) |
| 2022 | $1,858 | 97 | GlaxoSmithKline, LLC. ($293.85) |
| 2021 | $1,557 | 109 | Novo Nordisk Inc ($184.13) |
| 2020 | $1,379 | 93 | AstraZeneca Pharmaceuticals LP ($262.41) |
| 2019 | $2,083 | 122 | Janssen Pharmaceuticals, Inc ($398.57) |
| 2018 | $1,648 | 103 | Novo Nordisk Inc ($310.63) |
| 2017 | $2,005 | 179 | Novo Nordisk Inc ($265.16) |
All Payment Transactions
783 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Gastroenterology | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes Care | ||||||
| 08/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.71 | General |
| Category: NEUROLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: UROLOGY | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), TRADJENTA, JARDIANCE | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Obesity | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Gastroenterology | ||||||
| 06/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: PAIN | ||||||
| 06/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Cardio-renal | ||||||
| 06/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 646 | 1,096 | $77,583 | $38,916 |
| 2022 | 19 | 1,054 | 1,690 | $129,740 | $65,859 |
| 2021 | 17 | 1,098 | 1,927 | $143,913 | $70,440 |
| 2020 | 21 | 1,288 | 2,136 | $156,065 | $68,895 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 441 | $43,218 | $22,908 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 92 | $14,168 | $6,626 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $5,375 | $5,235 | 97.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 55 | 71 | $2,130 | $931.52 | 43.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 83 | 100 | $2,000 | $840.00 | 42.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 81 | 110 | $4,400 | $837.10 | 19.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 75 | $3,375 | $610.72 | 18.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 61 | $1,525 | $580.72 | 38.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 22 | 51 | $612.00 | $243.48 | 39.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 30 | $450.00 | $102.30 | 22.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 15 | 22 | $330.00 | $1.60 | 0.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 252 | 641 | $62,881 | $31,774 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $11,649 | $11,288 | 96.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 115 | $17,736 | $9,174 | 51.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 113 | $7,232 | $3,254 | 45.0% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 23 | 24 | $5,112 | $2,106 | 41.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 20 | 26 | $3,354 | $1,647 | 49.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 79 | 104 | $3,120 | $1,376 | 44.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 25 | 27 | $3,618 | $1,280 | 35.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 20 | 21 | $2,814 | $1,050 | 37.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 40 | 78 | $3,510 | $718.80 | 20.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 47 | 69 | $1,698 | $662.02 | 39.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 60 | 67 | $2,680 | $513.23 | 19.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 40 | 40 | $640.00 | $247.76 | 38.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 42 | 43 | $645.00 | $221.44 | 34.3% |
About Dr. Richard Norfleet, MD
Dr. Richard Norfleet, MD is a Family Medicine healthcare provider based in Cynthiana, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467407551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Norfleet, MD has received a total of $12,308 in payments from pharmaceutical and medical device companies, with $935.95 received in 2024. These payments were reported across 783 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($12,271).
As a Medicare-enrolled provider, Norfleet has provided services to 4,086 Medicare beneficiaries, totaling 6,849 services with total Medicare billing of $244,110. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cynthiana, KY
- Active Since 05/24/2006
- Last Updated 09/27/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1467407551
Products in Payments
- FARXIGA (Drug) $1,182
- XARELTO (Drug) $982.71
- TRELEGY ELLIPTA (Drug) $749.10
- VRAYLAR (Drug) $497.66
- Kerendia (Drug) $430.91
- ELIQUIS (Drug) $336.29
- Saxenda (Drug) $292.37
- Ozempic (Drug) $281.97
- CHANTIX (Drug) $271.11
- ENTRESTO (Drug) $268.18
- JARDIANCE (Drug) $267.82
- INVOKANA (Drug) $250.78
- TRULICITY (Drug) $247.10
- MYRBETRIQ (Drug) $239.54
- XIFAXAN (Drug) $230.13
- JANUVIA (Drug) $229.50
- Vascepa (Drug) $217.47
- Victoza (Drug) $209.34
- Xultophy 100/3.6 (Drug) $193.56
- ANORO (Drug) $184.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cynthiana
Brian Mulberry, Md, MD
Family Medicine — Payments: $17,475
Dr. Stephen Moses, M.d, M.D
Family Medicine — Payments: $11,158
John Cooper, Md, MD
Family Medicine — Payments: $7,084
Ardy Wright, M.d, M.D
Family Medicine — Payments: $5,343
Richard Risher, M.d, M.D
Family Medicine — Payments: $2,161
Maurice Mcglone, Do, DO
Family Medicine